Business Description
U-Neuron Biomedical Inc
ISIN : TW0006973001
Total Employee Number:
143Description
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 38.97 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.39 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 15.61 | |||||
Beneish M-Score | -2.25 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.3 | |||||
3-Year EBITDA Growth Rate | 23.2 | |||||
3-Year EPS without NRI Growth Rate | 19.3 | |||||
3-Year FCF Growth Rate | 4 | |||||
3-Year Book Growth Rate | 52.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.06 | |||||
9-Day RSI | 55.19 | |||||
14-Day RSI | 52.4 | |||||
3-1 Month Momentum % | -8.77 | |||||
6-1 Month Momentum % | -9.39 | |||||
12-1 Month Momentum % | -4.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 16.48 | |||||
Quick Ratio | 16.2 | |||||
Cash Ratio | 15.73 | |||||
Days Inventory | 150.47 | |||||
Days Sales Outstanding | 29.18 | |||||
Days Payable | 28.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7 | |||||
Shareholder Yield % | 2.06 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.01 | |||||
Operating Margin % | -78.85 | |||||
Net Margin % | -66.89 | |||||
EBITDA Margin % | -48.57 | |||||
FCF Margin % | -103.53 | |||||
OCF Margin % | -50.04 | |||||
ROE % | -7.32 | |||||
ROA % | -6.93 | |||||
ROIC % | -55.81 | |||||
3-Year ROIIC % | -19.53 | |||||
ROC (Joel Greenblatt) % | -63.61 | |||||
ROCE % | -7.14 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 15.86 | |||||
PB Ratio | 1.83 | |||||
Price-to-Tangible-Book | 1.84 | |||||
EV-to-EBIT | -12.83 | |||||
EV-to-EBITDA | -17.47 | |||||
EV-to-Revenue | 8.48 | |||||
EV-to-FCF | -8.2 | |||||
| Price-to-Net-Current-Asset-Value | 2.2 | |||||
| Price-to-Net-Cash | 2.31 | |||||
Earnings Yield (Greenblatt) % | -7.79 | |||||
FCF Yield % | -6.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
U-Neuron Biomedical Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 82.663 | ||
| EPS (TTM) (NT$) | -1.42 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 37.49 | ||
| 14-Day RSI | 52.4 | ||
| 14-Day ATR (NT$) | 1.022954 | ||
| 20-Day SMA (NT$) | 33.13 | ||
| 12-1 Month Momentum % | -4.03 | ||
| 52-Week Range (NT$) | 31.3 - 53.5 | ||
| Shares Outstanding (Mil) | 38.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
U-Neuron Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
U-Neuron Biomedical Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
U-Neuron Biomedical Inc Frequently Asked Questions
What is U-Neuron Biomedical Inc(ROCO:6973)'s stock price today?
The current price of ROCO:6973 is NT$33.75. The 52 week high of ROCO:6973 is NT$53.50 and 52 week low is NT$31.30.
When is next earnings date of U-Neuron Biomedical Inc(ROCO:6973)?
The next earnings date of U-Neuron Biomedical Inc(ROCO:6973) is .
Does U-Neuron Biomedical Inc(ROCO:6973) pay dividends? If so, how much?
U-Neuron Biomedical Inc(ROCO:6973) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on U-Neuron Biomedical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers